Zhejiang Tianyu Pharmaceutical Co Ltd Tangible Net Worth Ratio
Zhejiang Tianyu Pharmaceutical Co Ltd tangible net worth ratio. Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Tangible Net Worth Ratio of 85.0% as of June 2026. This metric is calculated by deducting intangible assets (CN¥540.57 Million) from net assets (CN¥3.61 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Zhejiang Tianyu Pharmaceutical Co Ltd (300702) strategic investment index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2025)
Tangible net worth ratio of Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2025. This chart shows how Zhejiang Tianyu Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 85.0%, reflecting net assets of CN¥3.61 Billion with intangible assets of CN¥540.57 Million CNY. See working capital position of Zhejiang Tianyu Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Zhejiang Tianyu Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2013–2025)
Zhejiang Tianyu Pharmaceutical Co Ltd tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Zhejiang Tianyu Pharmaceutical Co Ltd (300702) total market value.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.5% | CN¥3.64 Billion | CN¥491.69 Million | CN¥6.59 Billion | ▼ -0.2 pp |
| 2024 | 86.7% | CN¥3.50 Billion | CN¥464.72 Million | CN¥6.58 Billion | ▼ -0.5 pp |
| 2023 | 87.2% | CN¥3.49 Billion | CN¥445.66 Million | CN¥6.34 Billion | ▼ -0.6 pp |
| 2022 | 87.9% | CN¥3.50 Billion | CN¥423.94 Million | CN¥6.42 Billion | ▼ -2.0 pp |
| 2021 | 89.9% | CN¥3.71 Billion | CN¥374.75 Million | CN¥5.80 Billion | ▼ -3.3 pp |
| 2020 | 93.2% | CN¥3.55 Billion | CN¥241.34 Million | CN¥4.89 Billion | ▲ +1.3 pp |
| 2019 | 91.9% | CN¥2.04 Billion | CN¥165.71 Million | CN¥2.84 Billion | ▲ +2.2 pp |
| 2018 | 89.7% | CN¥1.45 Billion | CN¥149.65 Million | CN¥2.63 Billion | ▲ +1.6 pp |
| 2017 | 88.1% | CN¥1.29 Billion | CN¥153.24 Million | CN¥2.11 Billion | ▲ +6.7 pp |
| 2016 | 81.4% | CN¥607.31 Million | CN¥113.04 Million | CN¥1.52 Billion | ▼ -3.0 pp |
| 2015 | 84.4% | CN¥495.77 Million | CN¥77.44 Million | CN¥1.33 Billion | ▼ -5.0 pp |
| 2014 | 89.4% | CN¥456.22 Million | CN¥48.33 Million | CN¥1.08 Billion | ▲ +0.3 pp |
| 2013 | 89.1% | CN¥453.68 Million | CN¥49.48 Million | CN¥971.79 Million | — |